NCT04024059View on ClinicalTrials.gov

Contingency Management to Enhance Office-Based Buprenorphine Treatment

NACompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

June 30, 2023

Study Completion Date

July 1, 2024

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Contingency Management for adherence

Incentives contingent on buprenorphine adherence

BEHAVIORAL

Contingency Management for abstinence

Incentives contingent on opiate abstinence

Trial Locations (1)

21224

Center for Learning and Health, Baltimore

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Johns Hopkins University

OTHER

NCT04024059 - Contingency Management to Enhance Office-Based Buprenorphine Treatment | Biotech Hunter | Biotech Hunter